Signore, P. E., Guo, G., Wei, Z., Zhang, W., Lin, A., & Balzo, U. D. (2021). A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Signore, Pierre E., Guangjie Guo, Zhihua Wei, Weihua Zhang, Al Lin, y Ughetta Del Balzo. A Small-molecule Inhibitor of Hypoxia-inducible Factor Prolyl Hydroxylase Improves Obesity, Nephropathy and Cardiomyopathy in Obese ZSF1 Rats. Public Library of Science (PLoS), 2021.
Cita MLA (8a ed.)Signore, Pierre E., et al. A Small-molecule Inhibitor of Hypoxia-inducible Factor Prolyl Hydroxylase Improves Obesity, Nephropathy and Cardiomyopathy in Obese ZSF1 Rats. Public Library of Science (PLoS), 2021.